Beijing banned imports of Illumina’s gene-sequencing machines in response to U.S. tariffs.

Illumina slashes costs by $100 million after China bans its sequencers. The company lowers its 2025 EPS outlook and aims for ...

China banned the import of Illumina Inc. gene-sequencing machines as part of a wave of retaliatory trade measures in response to the US doubling tariffs on all Chinese goods.

Illumina is not banned from operating in the country and will continue to serve its existing customers, a company ...

With most global sequencing done on Illumina’s machines, the company drives long-term profitability through scale and leadership in intellectual property. The strong integration of its solutions ...

China banned the import of Illumina Inc. gene-sequencing machines as part of a wave of retaliatory measures against fresh US ...

Enabled on Illumina sequencers and a new multimodal analysis platform, Illumina's spatial technology delivers unbiased whole-transcriptome profiling with cellular resolution and high sensitivity.

Investing.com -- Chinese stocks related to genetic sequencing experienced gains after Beijing implemented a ban on the import of machines from Illumina (NASDAQ:ILMN), a US-based company.

Illumina (ILMN) is reducing its forecast for this year’s financial performance and cutting $100M in spending because China barred sales of its ...